Safety and Efficacy Clinical Study of SNS-595 in Patients With Platinum-Resistant Ovarian Cancer
Public ClinicalTrials.gov record NCT00408603. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 2 Open-Label, Multicenter Study of SNS-595 Injection in Patients With Platinum-Resistant Ovarian Cancer
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this study is to evaluate the objective response rate, safety and identify potential biomarkers in platinum-resistant ovarian cancer patients treated with voreloxin injection given on a 28-day cycle.
Study identification
- NCT ID
- NCT00408603
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 183 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- Female
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Dec 20, 2006 (Actual)
- Primary completion
- Jun 9, 2010 (Actual)
- Completion
- Jun 9, 2010 (Actual)
- Last update posted
- Jul 27, 2017
2006 – 2010
United States locations
- U.S. sites
- 14
- U.S. states
- 11
- U.S. cities
- 13
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Premiere Oncology of Arizona | Scottsdale | Arizona | 85260 | — |
| Gynecologic Oncology Associates | Newport Beach | California | 92663 | — |
| Sharp Clinical Oncology Research | San Diego | California | 92123 | — |
| Stanford University | Stanford | California | 94305 | — |
| Medstar Research Institute at Washington Hospital Center | Washington D.C. | District of Columbia | 10010 | — |
| Oncology Specialists, S.C. at Luthern General Advanced Care Center | Park Ridge | Illinois | 60068 | — |
| Louisville Oncology Clinical Research Program | Louisville | Kentucky | 40202 | — |
| The Harry and Jeanette Weinberg Institute at Franklin Square | Baltimore | Maryland | 21237 | — |
| Massachusetts General Hospital | Boston | Massachusetts | 02114 | — |
| Dana-Farber Cancer Institute | Boston | Massachusetts | 02115 | — |
| Memorial Sloan Kettering Cancer Center (MSKCC) | New York | New York | 10021 | — |
| Kaiser Permanente NW Region | Portland | Oregon | 97227 | — |
| University of Pittsburgh Medical Center at Magee-Womens Hospital | Pittsburgh | Pennsylvania | 15213 | — |
| Hall and Martin, MD's, P.C. | Knoxville | Tennessee | 37920 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 6 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00408603, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jul 27, 2017 · Synced Oct 27, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT00408603 live on ClinicalTrials.gov.